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For tissue engineering (TE) applications, the natural process of regener-
ation is imitated by using bioresorbable scaffolds that support cellular
attachment, migration and proliferation, along with cells capable of dif-
ferentiation upon exposure to inductive factors. Based on the idea of
combining a fully degradable polymer (Poly(-caprolactone; PCL) with
a thermoresponsive polymer (polyethylene glycol methacrylate, PEG-
MA) a scaffold was developed, which liquefies at 4 C and solidifies at
37 C. Adult stem cells, which can be obtained out of human fat tissue,
have the ability to be cultured in vitro and the potential to differentiate
into various lineages, including the osteogenic and adipogenic lineage.
There are several advantages using adipose-derived stem cells (ASCs),
for instance the possibility to isolate large amounts in an easy way or
the possibility to use them in an autologous setting. The mouse C2C12
cell line also features stem cell characteristics and has the potential to
differentiate towards the myocyte as well as osteocyte lineage. In this
study, the novel thermoresponsive material PCL-PEGMA was combined
with C2C12 cells or human ASCs to generate an expandable 3D con-
struct for soft or bone TE, depending on the in vitro differentiation con-
ditions. As a first step, biomaterial seeding for C2C12 cells as well as
ASCs was optimized and their attachment, survival, distribution and
persistence within the 3D material was characterized using viability
assays, fluorescence microscopy and scanning electron microscopy.
C2C12 cells as well as ASCs attached to the polymers were viable and
evenly distributed in all scaffolds. For C2C12 differentiation, the cells
were seeded 3D within the scaffold and stimulated with either osteo-
genic or myogenic differentiation medium for 7 days. The ASC-scaffold
constructs were cultured in media supporting either adipogenic or oste-
ogenic differentiation of ASCs for 21 days. 3D differentiation of the
cells was examined using qRT-PCR for differentiation specific markers.
Interestingely, C2C12 cells differentiated in the myogenic lineage as
well as ASCs treated with adipogenic differentiation medium showed
increased marker expression in 3D compared to 2D, suggesting that the
thermoresponsive PCL-PEGMA scaffold qualifies for 3D differentiation.
Conclusion: The thermoresponsive scaffold presented in this study is a
suitable material for 3D soft tissue engineering. The properties of the
material show limited potential to support osteogenic differentiation of
C2C12 or ASCs. In contrast, the matrix allows the attachment of
C2C12 cells as well as ASCs and was able to support 3D myogenic dif-
ferentiation of C2C12 cells and 3D adipogenic differentiation of ASCs.
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Spinal cord injuries (SCI) still remain a major challenge in current bio-
medical research. In spite of several advances in the understanding of
its mechanisms there has not been an equal significant translation into
the clinics. As a result, there is no effective treatment that can overcome
the biochemical and cellular adverse reactions that lead to a chronic
severely impaired condition. One of the first opportunities to minimize
these drastic consequences is to control the secondary events that fol-
low the trauma. We are proposing the local delivery of an anti-inflam-
matory corticosteroid - methylprednisolone (MP) – in an attempt to
modulate the noxious effects of the inflammation in the acute SCI. A
sustained delivery as the one provided by these nanoparticles (NP) can
be highly advantageous, maximizing the drug’s potency in the target
site. Therefore, we synthesized MP-loaded NPs composed of an inner
poly/(amido)amine (PAMAM) dendrimeric core and grafted with car-
boxymethylchitosan (CMCht). Chemical and biological characteriza-
tion studies were carried out showing that the NPs are stable in acidic
and neutral buffer solutions. Also, the viability of primary glial cultures
was not compromised by the presence of 200 lg/mL of NP. In turn, an
MP action in microglial cultures was observed in dosages above 1 mg/
mL showing that MP is being released from the NPs inside the cells.
The uptake profile of these NPs is time dependent and reaches its maxi-
mum 24 h after incubation with astrocytes, oligodendrocytes and
microglia. In a preview of a possible therapeutic effect, the NPs were
administered in hemisected spinal cord injured rats. To assess the effi-
cacy of local injections around the lesion site the animals were sacri-
ficed 3 h after surgery and frozen sections were observed. The
fluorescently labeled-NPs were detected in the injury and in the sur-
rounding spinal tissue indicating a successful delivery of the NP to the
spinal tissue. The local injections were repeated in hemisected rats that
were kept for 1 month, performing the BBB locomotory test weekly.
Significant differences in the BBB test were found between the MP-
loaded NPs injected rats and the sham group as well as the ones
injected with MP, demonstrating a favorable action of the MP-NPs in
the acute phase of the injury. This work revealed that sustained deliv-
ery of MP via a NP system can be highly beneficial in the management
of the secondary injury that follows SCI improving the overall func-
tional outcome of the injured animals.
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